↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.0MSold on the market
1Companies
Oct 15, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 202618:15 | Oct 15, 2026 | ORKAOruka Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $74.81 | −7,000 | 31,771 | -18% | −$524K | ||
| Oct 15, 202618:15 | Oct 15, 2026 | ORKAOruka Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $7.32 | +7,000 | 38,771 | +22% | $51K | ||
| Sep 15, 202619:18 | Sep 15, 2026 | ORKAOruka Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $92.38 | −7,947 | 31,771 | -20% | −$734K | ||
| Sep 15, 202619:18 | Sep 15, 2026 | ORKAOruka Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $7.32 | +7,000 | 39,718 | +21% | $51K | ||
| Aug 17, 202618:09 | Aug 17, 2026 | ORKAOruka Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $111.84 | −7,000 | 32,718 | -18% | −$783K | ||
| Aug 17, 202618:09 | Aug 17, 2026 | ORKAOruka Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $7.32 | +7,000 | 39,718 | +21% | $51K |